EXEL
EXELIXIS, INC. · Healthcare · Market cap $16.0B
Insiders sold $7.1M net in the last 90 days ·7 sellers, 0 buyers· 4 of 7 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 12, 2026
Insider Buying
$1.2M
reported purchases (SEC code P)
Insider Selling
$42.2M
reported sales (SEC code S)
Unique Insiders
13
in the rolling window
Latest filing
Aug 12, 2026
Beckerle Mary C
EXELIXIS, INC. (EXEL) has 52 SEC Form 4 filings (91 transaction rows) in the rolling window, disclosed by 13 distinct insiders. Most recent filing: Aug 12, 2026.
Inside the rolling window, 13 insiders at EXELIXIS, INC. reported 1 open-market purchase totaling $1.2M and 26 open-market sales totaling $42.2M. The most active filer is EVP, Research and Development Aftab Dana with 4 filings. Insiders have net sold $31.8M over the trailing 6 months. The most recent open-market filing is a sale of 9,812 shares by Director Beckerle Mary C, dated Aug 10, 2026, worth $527K.
- Industry:Biotechnology
- CEO:Michael Morrissey
- Employees:1,077
- HQ:Alameda, CA, US
- IPO:2000-04-17
| Source | |||||||
|---|---|---|---|---|---|---|---|
Beckerle Mary CFirst in 3 months | Director | Sale | 9,812 | $527K | Aug 12 | +28.2% | SEC ↗ |
WYSZOMIERSKI JACK LFirst in 3 months | Director | Sale | 3,925 | $198K | Jun 3 | +25.2% | SEC ↗ |
Eckhardt Sue GailFirst in 4 months | Director | Sale | 9,812 | $492K | Jun 3 | +25.2% | SEC ↗ |
Aftab DanaFirst in 3 months | EVP, Research and Development | Sale | 43,451 | $2.2M | May 28 | +25.5% | SEC ↗ |
Haley Patrick J.First in 3 months | EVP, Commercial | Sale | 32,110 | $1.6M | May 22 | +28.8% | SEC ↗ |
Senner Christopher J.First in 3 months | EVP and CFO | Sale | 34,901 | $1.7M | May 19 | +32.7% | SEC ↗ |
Hefti BrendaFirst in 3 months | SVP and General Counsel | Sale | 6,625 | $333K | May 19 | +32.7% | SEC ↗ |
Beckerle Mary CFirst in 6 months | Director | Sale | 7,712 | $374K | May 8 | +34.1% | SEC ↗ |
Freire Maria CFirst filing | Director | Sale | 20,634 | $949K | May 8 | +34.1% | SEC ↗ |
POSTE GEORGEFirst filing | Director | Sale | 60,000 | $2.7M | May 8 | +34.1% | SEC ↗ |
| EVP, Research and Development | Sale | 47,918 | $2.1M | Feb 26 | — | SEC ↗ | |
Aftab DanaFirst in 3 months | EVP, Research and Development | Sale | 29,873 | $1.3M | Feb 23 | — | SEC ↗ |
WYSZOMIERSKI JACK LFirst filing | Director | Sale | 99,574 | $4.4M | Feb 20 | — | SEC ↗ |
Smith JulieFirst filing | Director | Sale | 42,422 | $1.8M | Feb 19 | — | SEC ↗ |
Smith JulieFirst filing | Director | Sale | 64,117 | $2.8M | Feb 19 | — | SEC ↗ |
Senner Christopher J.First filing | EVP and CFO | Sale | 34,278 | $1.5M | Feb 18 | — | SEC ↗ |
Senner Christopher J.First filing | EVP and CFO | Sale | 30,617 | $1.3M | Feb 18 | — | SEC ↗ |
| EVP, Commercial | Sale | 67,814 | $3.0M | Feb 18 | — | SEC ↗ | |
Oliver BobFirst filing | Director | Sale | 30,250 | $1.3M | Feb 18 | — | SEC ↗ |
Hefti BrendaFirst filing | SVP and General Counsel | Sale | 18,669 | $822K | Feb 18 | — | SEC ↗ |
Eckhardt Sue GailFirst filing | Director | Sale | 3,856 | $169K | Feb 18 | — | SEC ↗ |
JOHNSON DAVID EDWARDFirst filing | Director | Purchase | 27,532 | $1.2M | Nov 26 | — | SEC ↗ |
Haley Patrick J.First filing | EVP, Commercial | Sale | 44,187 | $1.9M | Nov 24 | — | SEC ↗ |
Haley Patrick J.First filing | EVP, Commercial | Sale | 28,043 | $1.2M | Nov 24 | — | SEC ↗ |
Beckerle Mary CFirst filing | Director | Sale | 24,622 | $1.0M | Nov 13 | — | SEC ↗ |
Congress trading EXEL 6 all-time
- DRep. Ro KhannaSale$1,001 - $15,0002024-01-10
- DRep. Ro KhannaPurchase$1,001 - $15,0002022-12-06
- DRep. Donna ShalalaOther$1,001 - $15,0002019-06-04
- DRep. Donna ShalalaPurchase$1,001 - $15,0002019-02-06
- DRep. Donna ShalalaPurchase$1,001 - $15,0002019-01-09
- DRep. Donna ShalalaOther$1,001 - $15,0002019-04-16
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does EXEL have?
EXELIXIS, INC. (EXEL) has 52 SEC Form 4 filings (91 transaction rows) in the rolling 365-day window, disclosed by 13 distinct insiders. Most recent filing: Aug 12, 2026.
When was the most recent SEC Form 4 filing for EXEL?
The most recent Form 4 filing for EXEL on Tracefour is dated Aug 12, 2026.
Who is the most active insider at EXEL?
The most active SEC Form 4 filer at EXEL in the rolling window is EVP, Research and Development Aftab Dana, with 4 filings.
What is the net insider flow at EXEL over the last 6 months?
Over the trailing 180 days, insiders at EXEL have net sold $31.8M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at EXEL in the current window?
Inside the rolling window, insiders at EXEL bought $1.2M and sold $42.2M based on SEC Form 4 filings.
Can I get alerts for EXEL insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at EXELIXIS, INC. (EXEL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
EXELIXIS, INC. is in the Healthcare sector.